ライフサイエンスコーパス: test

1 and portable solution is in highly demand for point of care test.

2 and intake of cocaine in an intravenous self-administration test.

3 nate occlusion of the eyes and the conventional Hess screen test.

4 vs. EGFR-negative) was assessed using the Wilcoxon rank-sum test.

5 The unpaired t test and chi(2) analysis were used to determine significant d

6 xiety Disorder-7 scale, Alcohol Use Disorder Identification Test (AUDIT), and self-reported help-seeking from clinical an

7 henotypic consequences for disease-associated variants, and test causal inference.

8 A sectors approach shows good screening test characteristics for the detection of CSME.

9 Test characteristics were not improved with the addition of l

10 disease risk scores with an echocardiogram, exercise stress test, computerized tomographic coronary angiogram, and cardio

11 Since efficient leprosy diagnosis requires field-friendly test conditions, we evaluated two rapid lateral flow assays (

12 To test for cis genetic elements required for Pxr function, we d

13 Immunofluorescence is a highly specific diagnostic test for PCD, and it improves the speed and availability of d

14 Here, we test for the first time how early-life stress drives developm

15 ntroduced variably truncated fragments of the pxr region to test for their ability to block development.

16 We used the Cochran-Armitage test for trend to examine trends in rates of antimicrobial re

17 c antibodies: the visual immunogold OnSite Leprosy Ab Rapid test [Gold-LFA] and the quantitative, luminescent up-converti

18 Poirel (rapid polymyxin NP test) in 2016, detects glucose metabolization in the presence

19 To compare and test its scalability, the model was also run with 271 coral c

20 abnormalities in syphilis underwent the mental alternation test (MAT), venipuncture, and lumbar puncture.

21 esent an important foundation for developing a standardized test methodology for determination of laser-induced nanoparti

22 Here, we conduct a strong test of the saliency hypothesis by comparing the output of a

23 lubility and absorption, pasting properties, reconstitution test, proximate composition, amino acids, minerals and electr

24 Regression analysis, correlation coefficient analysis, and test-retest validation were conducted.

25 anobeads-peptide moieties away from the sensor surface upon test sample dropping.

26 The Sino-Nasal Outcome Test score might be able to predict more severe reactions and

27 For the test set, sensitivity ranged from 67% (rio zona) to 100% (sof

28 ns of extant mammals (47 species) and birds (59 species) to test six possible morphological-functional associations betwe

29 /-) mouse model with a consistent cleft palate phenotype to test small-molecule Wnt agonist therapies.

30 ther independent, somewhat correlated, or highly correlated test statistics.

31 The cost for the cohort, which included the cost of the test, subsequent treatments received, and health care encount

32 All participants had (13)C-spirulina GE breath test T1/2 values of 79 minutes or more (with 89.8% delayed re

33 Fmr1 knock-out (KO) mice, a model of Fragile-X Syndrome, to test the E/I imbalance theory.

34 To test the generality of this finding, DFT was also employed to

35 To test the hypothesis that ICP monitoring is associated with im

36 Here, we test the hypothesis that laropiprant limits bleeding and resc

37 To test the hypothesis that SOD delivery to caveolae may specifi

38 C infusion of a BDNF-neutralizing antibody was performed to test the necessity of BDNF release in driving scopolamine-ind

39 To test the non-tumor cell microenvironment role of RAGE, we per

40 To test the physiological relevance of noncanonical TR signaling

41 Additional studies are required to test the prognostic significance of CNA presence in disease r

42 hoproteomic approach in CRF-overexpressing (CRF-OE) mice to test the proof of principle that when CRF is in excess, sex-b

43 To test this hypothesis, we created a mouse model in which a por

44 quantitative, luminescent up-converting phosphor anti-PGL-I test [UCP-LFA].

45 ian time of day for extubation with an extubation readiness test was 12:15 hours compared with 14:54 hours for extubation

46 For detection of HPV types, a Roche Linear Array test was performed.

47 sed for comparison of lipid profile, whereas Kruskal-Wallis test was used for comparison of FMD and PISA scores among the

48 The Wilcoxon signed rank test was used to assess for differences among treatment group

49 Here, we used chimeric proteins to test whether DAT and SERT N and C termini contribute to trans

50 14:54 hours for extubation without an extubation readiness test within 10 hours (p < 0.001).